Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Technology Feature
  • Published:

The DNA of a nation

The United Kingdom aims to sequence 100,000 human genomes by 2017. But screening them for disease-causing variants will require innovative software.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Bainbridge, M. N. et al. Sci. Transl. Med. 3, 87re3 (2011).

    Article  Google Scholar 

  2. Taylor, J. C. et al. Nature Genet. 47, 717–726 (2015).

    Article  CAS  Google Scholar 

  3. Raczy, C. et al. Bioinformatics 29, 2041–2043 (2013).

    Article  CAS  Google Scholar 

  4. Wright, C. F. et al. Lancet 385, 1305–1314 (2015).

    Article  Google Scholar 

  5. Singleton, M. V. et al. Am. J. Hum. Genet. 94, 599–610 (2014).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Marx, V. The DNA of a nation. Nature 524, 503–505 (2015). https://doi.org/10.1038/524503a

Download citation

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/524503a

This article is cited by

Comments

Commenting on this article is now closed.

  1. To the editor:

    Genomic analysis of a nation: the case of basic research

    The Begley _et a _l.'s article (1) [The DNA of a nation, Nature], addresses an important project in the United Kingdom that seeks to sequence 100,000 genomes from National Health Service (NHS) patients with cancer, rare disorders and infectious diseases (1). Given the outreach of this project, it will boost the development of bioinformatics and genomics.

    In my view, this initiative should be replicated in other countries, as the benefits clearly outweighs the cost. If the genomic information is made available to all research groups in any country, it would be possible to conduct translational studies according to the size of the population, and obtain a genomic population map with immeasurable benefits.

    Sincerely,
    Carlos Polanco, Ph.D., D.Sc.
    Universidad Nacional Autónoma de México, México City, México.

    Carlos Polanco is an Associate Professor in the Facuty of Sciences at Universidad Nacional Autónoma de México, México City, México. (polanco@unam.mx)

    References

    1. Vivien, M. Nature 524, 503-505 (2015).

Search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research